Tuba Dal
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 10%
- Infections and bacterial resistance
Papers in
-
- Antibiotic Resistance in Bacteria 16
-
- Infection Control in Healthcare 7
- Antifungal resistance and susceptibility 5
- Co-authors
- Recep Tekin (22 shared papers)Rıza Durmaz (12 shared papers)Khudaverdi Ganbarov (3 shared papers)Hossein Samadi Kafil (3 shared papers)Şükran Köse (4 shared papers)Sounkalo Dao (2 shared papers)Ziya Cibali Açıkgöz (6 shared papers)Mohammad Ahangarzadeh Rezaee (2 shared papers)
- Journals
- Epidemiology and Infection (1 paper)Journal of Medical Microbiology (1 paper)Diagnostic Microbiology and Infectious Disease (1 paper)Microbial Pathogenesis (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)
- Partner nations
- TürkiyeAzerbaijanIran
In The Last Decade
Tuba Dal
78 papers receiving 952 citations
Peers
Comparison fields: 5 of 92
- Molecular Medicine 202
- Endocrinology 52
- Applied Microbiology and Biotechnology 29
- General Dentistry 5
- Infectious Diseases 190
Countries citing papers authored by Tuba Dal
This map shows the geographic impact of Tuba Dal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuba Dal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuba Dal more than expected).
Fields of papers citing papers by Tuba Dal
This network shows the impact of papers produced by Tuba Dal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuba Dal. The network helps show where Tuba Dal may publish in the future.
Co-authors
The 25 scholars most cited alongside Tuba Dal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 129 | |
| 2 | Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. | 2020 | 116 |
| 3 | 2013 | 45 | |
| 4 | 2018 | 39 | |
| 5 | 2019 | 37 | |
| 6 | 2013 | 35 | |
| 7 | 2019 | 31 | |
| 8 | 2020 | 28 | |
| 9 | 2018 | 24 | |
| 10 | 2019 | 24 | |
| 11 | 2013 | 23 | |
| 12 | Is Chryseobacterium indologenes a shunt-lover bacterium? A case report and review of the literature. | 2013 | 20 |
| 13 | 2013 | 19 | |
| 14 | 2015 | 17 | |
| 15 | 2019 | 17 | |
| 16 | 2020 | 17 | |
| 17 | 2014 | 16 | |
| 18 | 2014 | 15 | |
| 19 | 2014 | 15 | |
| 20 | 2011 | 14 |
About Tuba Dal
Tuba Dal is a scholar working on Molecular Medicine, Infectious Diseases, Endocrinology, Epidemiology and Clinical Biochemistry, having authored 87 papers that have together received 994 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (16 papers), Hepatitis B Virus Studies (8 papers), Infection Control in Healthcare (7 papers), Bacterial Identification and Susceptibility Testing (6 papers), Urinary Tract Infections Management (6 papers), Infections and bacterial resistance (6 papers), Antifungal resistance and susceptibility (5 papers) and Brucella: diagnosis, epidemiology, treatment (5 papers). The work is most often cited by research in Molecular Medicine (202 citations), Endocrinology (52 citations), Applied Microbiology and Biotechnology (29 citations), General Dentistry (5 citations) and Infectious Diseases (190 citations). Tuba Dal has collaborated with scholars based in Türkiye, Azerbaijan and Iran. Frequent co-authors include Recep Tekin, Rıza Durmaz, Khudaverdi Ganbarov, Hossein Samadi Kafil, Şükran Köse, Sounkalo Dao, Ziya Cibali Açıkgöz, Mohammad Ahangarzadeh Rezaee, Pourya Gholizadeh and Mohammad Hossein Aghazadeh. Their work appears in journals such as Epidemiology and Infection, Journal of Medical Microbiology, Diagnostic Microbiology and Infectious Disease, Microbial Pathogenesis and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.